Rodman & Renshaw Initiates NuVasive at Market Perform (NUVA)

Share this story with your network

By Chip Brian, SmarTrend Analytics Team

01/08/2010-NuVasive (NASDAQ:NUVA) was initiated at Rodman & Renshaw Friday with a Market Perform.

The firm says NuVasive’s position as the #5 player in spine surgery sector mandates its rating.

Furthermore, the firm says the spine surgery sector currently is valued at $8 billion and has favorable growth drivers such as the aging population and rising obesity behind it.

However, the firm remains cautious due to its belief that a market-wide shock could have a multiplier effect on NuVasive given its lack of diversification.

Contact Chip Brian

Leave a Comment

Your email address will not be published. Required fields are marked *